Cached score snapshot

US.VRTX · Vertex Pharmaceuticals

110分制 60.6/110；5D動能v2 5/50；排序分 65.6/160

Back to ranking Open volume snapshot

Ranking score 65.6/160

Main score 60.6/110

5D momentum v2 5/50

Rank #188

Setup grade D 36

Score breakdown

觀望

Medium database-backfill

Score and price trend

D 36 Technical A · Low sample confidence

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

**Historical projection**
Model	Median	P25/P75	歷史相似情境上漲比例	Down5	Actual / compare
Rolling DOE best · score 2.933 · anchors 120	-0.51%	-2.14% / +1.86%	42.8%	5.3%	Actual -2.49% · vs median -1.98% · inside 25-75 band
30D observation	-4.25%	-11.72% / +5.30%	34.1%	46.6%	Actual outcome pending · 12 / 30 bars observed
Historical projection 10D n=160	-0.29%	-1.71% / +2.30%	46.3%	3.8%	Actual +4.47% · vs median +4.76% · inside 25-75 band

歷史情境統計基於已存檔相似 setup；圖中投影中位線為統計中位數的線性插值展示，並非價格路徑預測或買賣建議。

2026-03-12 → 2026-07-20 · 327 archived points · 1 Improving turn signal · 7 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 65.6

Display grade 觀望

Model version cursor_18_27_news_v2_160

Main score 60.6/110 (觀望)

5D momentum v2 5/50 (弱)

Score with momentum v2 65.6/160 (低排序)

Risk level Medium

Audit trace

Full calculation detail

Calculation detail · 4 sections

Market inputs

Bar count 238

ma20 438.6075

ma50 436.9404

close 446.83

prevClose 441.74

avgVolume20 1339205

volumeRatio 1.14

changePercent 1.15

Metrics snapshot

close 446.83

volume 1530000

changePercent 1.15

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 60.6/110

Main rating 觀望

5D momentum v2 5/50

Score with momentum v2 65.6/160

Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 3.8/5 · 良好

Dimension score 3.8/5

Dimension grade 良好

No sub-item breakdown recorded.

資金流 — 11.6/20 · 較差

Dimension score 11.6/20

Dimension grade 較差

No sub-item breakdown recorded.

市場環境 — 8.4/15 · 較差

Dimension score 8.4/15

Dimension grade 較差

No sub-item breakdown recorded.

催化劑 — 2/20 · 較差

Dimension score 2/20

Dimension grade 較差

No sub-item breakdown recorded.

風險管理 — 7.2/10 · 良好

Dimension score 7.2/10

Dimension grade 良好

No sub-item breakdown recorded.

技術信號 — 23.6/30 · 良好

Dimension score 23.6/30

Dimension grade 良好

No sub-item breakdown recorded.

情緒分析 — 4/10 · 較差

Dimension score 4/10

Dimension grade 較差

No sub-item breakdown recorded.

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 5/50

ret_5d -0.0016

raw_total 5

vcp_bonus 0

ret_points 0

vol_points 2

breakout_points 0

Risk management

level Medium

reason risk management score >= 6.5/10

position

score 1.6

details

atrPct 2.5113

turnoverUsdM 683.6499

liquidityPoints 0.6

volatilityPoints 1

rrPoints 1.8

stopLevels

symbol US.VRTX

rr_range 1:1.0-1:2.5

risk_profile 中等

stop_loss_price 424.3872

strength_details

ma_score 2

atr_score 2

rsi_score 2

macd_score 3

volume_score 2

market_adjustment 1

risk_reward_ratio 1.7

stop_loss_percent 5

take_profit_price 483.8606

target_multiplier 2.2

technical_strength 2.25

take_profit_percent 8.3

positionPoints 1.6

stopLossPoints 1.8

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used

sector Health Care

concentratedSectorPenalty 0

riskRewardRatio 1.6525

stopLossPercent 5.0227

diversificationPoints 2

Raw calculation JSON

{
  "risk": {
    "level": "Medium",
    "reason": "risk management score >= 6.5/10",
    "position": {
      "score": 1.6,
      "details": {
        "atrPct": 2.51133546340522,
        "turnoverUsdM": 683.6498847,
        "liquidityPoints": 0.6,
        "volatilityPoints": 1
      }
    },
    "rrPoints": 1.8,
    "stopLevels": {
      "symbol": "US.VRTX",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 424.3872,
      "strength_details": {
        "ma_score": 2,
        "atr_score": 2,
        "rsi_score": 2,
        "macd_score": 3,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1.7,
      "stop_loss_percent": 5,
      "take_profit_price": 483.8606,
      "target_multiplier": 2.2,
      "technical_strength": 2.25,
      "take_profit_percent": 8.3
    },
    "positionPoints": 1.6,
    "stopLossPoints": 1.8,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.6525072259254643,
    "stopLossPercent": 5.02267092681044,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 65.6,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 60.6,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 5
  },
  "market": {
    "ma20": 438.6075,
    "ma50": 436.9404,
    "close": 446.83,
    "prevClose": 441.74,
    "avgVolume20": 1339205,
    "volumeRatio": 1.14,
    "changePercent": 1.15
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 238,
  "momentum": {
    "max": 50,
    "result": 5,
    "details": {
      "ret_5d": -0.0015864950264445898,
      "raw_total": 5,
      "vcp_bonus": 0,
      "ret_points": 0,
      "vol_points": 2,
      "breakout_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "觀望",
    "result": 60.6,
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 3.8,
      "資金流": 11.6,
      "市場環境": 8.4,
      "情緒分析": 4,
      "技術信號": 23.6,
      "風險管理": 7.2
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差"
      },
      "基本面": {
        "max": 5,
        "grade": "良好",
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差"
      },
      "市場環境": {
        "max": 15,
        "grade": "較差"
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差"
      },
      "技術信號": {
        "max": 30,
        "grade": "良好"
      },
      "風險管理": {
        "max": 10,
        "grade": "良好"
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ]
  }
}

Raw metrics JSON

{
  "close": 446.83,
  "volume": 1530000,
  "changePercent": 1.15
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.